Insights and News

Close up of a paediatrician having a check up on his patient
6 min read

5 pieces of advice for designing successful digital products for those with rare diseases

Leslie BIMA 100 nomination
4 min read

Graphite’s Senior Project Manager recognised in the 2022 BIMA 100

Folded pink and purple hexagon graphic on grey background
4 min read

The Contradiction Conundrum: Download our new digital pharma report

A whiteboard with pink post-it notes stuck on it. There is a plant in a pot on the floor to the right of the whiteboard
6 min read

The digital pharma product development process: 10 stages

7 people sat around a large table having a meeting together
5 min read

Designing compliant digital pharma products: Overcoming us vs them

Close of of two women's hands as they point at a computer screen
6 min read

Heuristic evaluation: what, how and why

workshop
3 min read

Apply for Work Experience with Graphite: Summer 2022

A couple sitting at a table outside on a telehealth appointment

How can digital enhance the support tools provided for patients with rare disease?

In the world of rare and ultra rare diseases, there is huge scope for digital tools, services and platforms to enhance the patient experience. Recently, we’ve noticed that increasing numbers of pharmaceutical companies are looking to improve and augment their patient-facing digital tools in order to offer a more holistic approach to rare disease treatment, and help empower patients to manage their condition. Here, we take a look at the possible role and benefits of an increased focus on digital in this field.